Report Cover

Global TDS(Transdermal Delivery Systems) Sales Market Report 2021


The global TDS(Transdermal Delivery Systems) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
    Single-layer Drug-in-Adhesive
    Multi-layer Drug-in-Adhesive
    Others

Segment by Application
    Hospital
    Clinic
    Other

The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries). Segment by Application, the TDS(Transdermal Delivery Systems) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
    Adhex Pharma
    Harro Hofliger
    Tesa Labtec
    Toyochem
    Teva Pharmaceutical
    Pfizer
    IBSA Group
    Teikoku Seiyaku
    Endo International
    Hisamitsu
    Mylan
    Sorrento Therapeutics
1 TDS(Transdermal Delivery Systems) Market Overview
    1.1 TDS(Transdermal Delivery Systems) Product Scope
    1.2 TDS(Transdermal Delivery Systems) Segment by Type
        1.2.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2016 & 2021 & 2027)
        1.2.2 Single-layer Drug-in-Adhesive
        1.2.3 Multi-layer Drug-in-Adhesive
        1.2.4 Others
    1.3 TDS(Transdermal Delivery Systems) Segment by Application
        1.3.1 Global TDS(Transdermal Delivery Systems) Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 TDS(Transdermal Delivery Systems) Market Estimates and Forecasts (2016-2027)
        1.4.1 Global TDS(Transdermal Delivery Systems) Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global TDS(Transdermal Delivery Systems) Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global TDS(Transdermal Delivery Systems) Price Trends (2016-2027)

2 TDS(Transdermal Delivery Systems) Estimates and Forecasts by Region
    2.1 Global TDS(Transdermal Delivery Systems) Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2021)
        2.2.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2016-2021)
    2.3 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global TDS(Transdermal Delivery Systems) Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
        2.4.2 Europe TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
        2.4.3 China TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
        2.4.4 Japan TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
        2.4.6 India TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
3 Global TDS(Transdermal Delivery Systems) Competition Landscape by Players
    3.1 Global Top TDS(Transdermal Delivery Systems) Players by Sales (2016-2021)
    3.2 Global Top TDS(Transdermal Delivery Systems) Players by Revenue (2016-2021)
    3.3 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2020)
    3.4 Global TDS(Transdermal Delivery Systems) Average Price by Company (2016-2021)
    3.5 Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global TDS(Transdermal Delivery Systems) Market Size by Type
    4.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Type (2016-2021)
        4.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
        4.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2016-2021)
        4.1.3 Global TDS(Transdermal Delivery Systems) Price by Type (2016-2021)
    4.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2022-2027)
        4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2022-2027)
        4.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Type (2022-2027)
5 Global TDS(Transdermal Delivery Systems) Market Size by Application
    5.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Application (2016-2021)
        5.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
        5.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2016-2021)
        5.1.3 Global TDS(Transdermal Delivery Systems) Price by Application (2016-2021)
    5.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2022-2027)
        5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2022-2027)
        5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2022-2027)

6 North America TDS(Transdermal Delivery Systems) Market Facts & Figures
    6.1 North America TDS(Transdermal Delivery Systems) Sales by Company
        6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    6.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        6.2.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        6.2.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    6.3 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        6.3.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
        6.3.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)

7 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures
    7.1 Europe TDS(Transdermal Delivery Systems) Sales by Company
        7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    7.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        7.2.1 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        7.2.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    7.3 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China TDS(Transdermal Delivery Systems) Market Facts & Figures
    8.1 China TDS(Transdermal Delivery Systems) Sales by Company
        8.1.1 China TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        8.1.2 China TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    8.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        8.2.1 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        8.2.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    8.3 China TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        8.3.1 China 312 Sales Breakdown by Application (2016-2021)
        8.3.2 China 312 Sales Breakdown by Application (2022-2027)

9 Japan TDS(Transdermal Delivery Systems) Market Facts & Figures
    9.1 Japan TDS(Transdermal Delivery Systems) Sales by Company
        9.1.1 Japan TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        9.1.2 Japan TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    9.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        9.2.1 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        9.2.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    9.3 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia TDS(Transdermal Delivery Systems) Market Facts & Figures
    10.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company
        10.1.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        10.1.2 Southeast Asia TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    10.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        10.2.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India TDS(Transdermal Delivery Systems) Market Facts & Figures
    11.1 India TDS(Transdermal Delivery Systems) Sales by Company
        11.1.1 India TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
        11.1.2 India TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
    11.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type
        11.2.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
        11.2.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
    11.3 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application
        11.3.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
        11.3.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in TDS(Transdermal Delivery Systems) Business
    12.1 Adhex Pharma
        12.1.1 Adhex Pharma Corporation Information
        12.1.2 Adhex Pharma Business Overview
        12.1.3 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
        12.1.5 Adhex Pharma Recent Development
    12.2 Harro Hofliger
        12.2.1 Harro Hofliger Corporation Information
        12.2.2 Harro Hofliger Business Overview
        12.2.3 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
        12.2.5 Harro Hofliger Recent Development
    12.3 Tesa Labtec
        12.3.1 Tesa Labtec Corporation Information
        12.3.2 Tesa Labtec Business Overview
        12.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
        12.3.5 Tesa Labtec Recent Development
    12.4 Toyochem
        12.4.1 Toyochem Corporation Information
        12.4.2 Toyochem Business Overview
        12.4.3 Toyochem TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
        12.4.5 Toyochem Recent Development
    12.5 Teva Pharmaceutical
        12.5.1 Teva Pharmaceutical Corporation Information
        12.5.2 Teva Pharmaceutical Business Overview
        12.5.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
        12.5.5 Teva Pharmaceutical Recent Development
    12.6 Pfizer
        12.6.1 Pfizer Corporation Information
        12.6.2 Pfizer Business Overview
        12.6.3 Pfizer TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
        12.6.5 Pfizer Recent Development
    12.7 IBSA Group
        12.7.1 IBSA Group Corporation Information
        12.7.2 IBSA Group Business Overview
        12.7.3 IBSA Group TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
        12.7.5 IBSA Group Recent Development
    12.8 Teikoku Seiyaku
        12.8.1 Teikoku Seiyaku Corporation Information
        12.8.2 Teikoku Seiyaku Business Overview
        12.8.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
        12.8.5 Teikoku Seiyaku Recent Development
    12.9 Endo International
        12.9.1 Endo International Corporation Information
        12.9.2 Endo International Business Overview
        12.9.3 Endo International TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
        12.9.5 Endo International Recent Development
    12.10 Hisamitsu
        12.10.1 Hisamitsu Corporation Information
        12.10.2 Hisamitsu Business Overview
        12.10.3 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
        12.10.5 Hisamitsu Recent Development
    12.11 Mylan
        12.11.1 Mylan Corporation Information
        12.11.2 Mylan Business Overview
        12.11.3 Mylan TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Mylan TDS(Transdermal Delivery Systems) Products Offered
        12.11.5 Mylan Recent Development
    12.12 Sorrento Therapeutics
        12.12.1 Sorrento Therapeutics Corporation Information
        12.12.2 Sorrento Therapeutics Business Overview
        12.12.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Products Offered
        12.12.5 Sorrento Therapeutics Recent Development

13 TDS(Transdermal Delivery Systems) Manufacturing Cost Analysis
    13.1 TDS(Transdermal Delivery Systems) Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
    13.4 TDS(Transdermal Delivery Systems) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 TDS(Transdermal Delivery Systems) Distributors List
    14.3 TDS(Transdermal Delivery Systems) Customers

15 Market Dynamics
    15.1 TDS(Transdermal Delivery Systems) Market Trends
    15.2 TDS(Transdermal Delivery Systems) Drivers
    15.3 TDS(Transdermal Delivery Systems) Market Challenges
    15.4 TDS(Transdermal Delivery Systems) Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer

List of Tables Table 1. Global TDS(Transdermal Delivery Systems) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global TDS(Transdermal Delivery Systems) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global TDS(Transdermal Delivery Systems) Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Region (2016-2021) Table 5. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2021) Table 6. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global TDS(Transdermal Delivery Systems) Revenue Share by Region (2016-2021) Table 8. Global TDS(Transdermal Delivery Systems) Sales (K Units) Forecast by Region (2022-2027) Table 9. Global TDS(Transdermal Delivery Systems) Sales Market Share Forecast by Region (2022-2027) Table 10. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global TDS(Transdermal Delivery Systems) Revenue Share Forecast by Region (2022-2027) Table 12. Global TDS(Transdermal Delivery Systems) Sales (K Units) of Key Companies (2016-2021) Table 13. Global TDS(Transdermal Delivery Systems) Sales Share by Company (2016-2021) Table 14. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) by Company (2016-2021) Table 15. Global TDS(Transdermal Delivery Systems) Revenue Share by Company (2016-2021) Table 16. Global TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2020) Table 17. Global TDS(Transdermal Delivery Systems) Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites and Area Served Table 19. Manufacturers TDS(Transdermal Delivery Systems) Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2016-2021) Table 22. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2016-2021) Table 23. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Type (2016-2021) Table 25. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2022-2027) Table 26. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2022-2027) Table 28. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Type (2022-2027) Table 29. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2016-2021) Table 30. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2016-2021) Table 31. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Application (2016-2021) Table 33. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2022-2027) Table 34. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2022-2027) Table 35. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2022-2027) Table 37. Global TDS(Transdermal Delivery Systems) Price (USD/Unit) by Application (2022-2027) Table 38. North America TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 39. North America TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 40. North America TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 41. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 42. North America TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 43. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 44. North America TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 45. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 46. North America TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 47. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 48. North America TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 49. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 50. Europe TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 51. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 52. Europe TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 54. Europe TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 55. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 56. Europe TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 57. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 58. Europe TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 59. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 60. Europe TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 61. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 62. China TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 63. China TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 64. China TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 65. China TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 66. China TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 67. China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 68. China TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 69. China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 70. China TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 71. China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 72. China TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 73. China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 74. Japan TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 75. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 76. Japan TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 78. Japan TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 79. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 80. Japan TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 81. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 82. Japan TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 83. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 84. Japan TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 85. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 86. Southeast Asia TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 88. Southeast Asia TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 92. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 94. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 96. Southeast Asia TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 98. India TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2016-2021) Table 99. India TDS(Transdermal Delivery Systems) Sales Market Share by Company (2016-2021) Table 100. India TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021) & (US$ Million) Table 101. India TDS(Transdermal Delivery Systems) Revenue Market Share by Company (2016-2021) Table 102. India TDS(Transdermal Delivery Systems) Sales by Type (2016-2021) & (K Units) Table 103. India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021) Table 104. India TDS(Transdermal Delivery Systems) Sales by Type (2022-2027) & (K Units) Table 105. India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2022-2027) Table 106. India TDS(Transdermal Delivery Systems) Sales by Application (2016-2021) & (K Units) Table 107. India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021) Table 108. India TDS(Transdermal Delivery Systems) Sales by Application (2022-2027) & (K Units) Table 109. India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2022-2027) Table 110. Adhex Pharma Corporation Information Table 111. Adhex Pharma Description and Business Overview Table 112. Adhex Pharma TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Adhex Pharma TDS(Transdermal Delivery Systems) Product Table 114. Adhex Pharma Recent Development Table 115. Harro Hofliger Corporation Information Table 116. Harro Hofliger Description and Business Overview Table 117. Harro Hofliger TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Harro Hofliger TDS(Transdermal Delivery Systems) Product Table 119. Harro Hofliger Recent Development Table 120. Tesa Labtec Corporation Information Table 121. Tesa Labtec Description and Business Overview Table 122. Tesa Labtec TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. Tesa Labtec TDS(Transdermal Delivery Systems) Product Table 124. Tesa Labtec Recent Development Table 125. Toyochem Corporation Information Table 126. Toyochem Description and Business Overview Table 127. Toyochem TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. Toyochem TDS(Transdermal Delivery Systems) Product Table 129. Toyochem Recent Development Table 130. Teva Pharmaceutical Corporation Information Table 131. Teva Pharmaceutical Description and Business Overview Table 132. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product Table 134. Teva Pharmaceutical Recent Development Table 135. Pfizer Corporation Information Table 136. Pfizer Description and Business Overview Table 137. Pfizer TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Pfizer TDS(Transdermal Delivery Systems) Product Table 139. Pfizer Recent Development Table 140. IBSA Group Corporation Information Table 141. IBSA Group Description and Business Overview Table 142. IBSA Group TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. IBSA Group TDS(Transdermal Delivery Systems) Product Table 144. IBSA Group Recent Development Table 145. Teikoku Seiyaku Corporation Information Table 146. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Teikoku Seiyaku Description and Business Overview Table 148. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product Table 149. Teikoku Seiyaku Recent Development Table 150. Endo International Corporation Information Table 151. Endo International TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Endo International Description and Business Overview Table 153. Endo International TDS(Transdermal Delivery Systems) Product Table 154. Endo International Recent Development Table 155. Hisamitsu Corporation Information Table 156. Hisamitsu Description and Business Overview Table 157. Hisamitsu TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 158. Hisamitsu TDS(Transdermal Delivery Systems) Product Table 159. Hisamitsu Recent Development Table 160. Mylan Corporation Information Table 161. Mylan Description and Business Overview Table 162. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 163. Mylan TDS(Transdermal Delivery Systems) Product Table 164. Mylan Recent Development Table 165. Sorrento Therapeutics Corporation Information Table 166. Sorrento Therapeutics Description and Business Overview Table 167. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 168. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product Table 169. Sorrento Therapeutics Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. TDS(Transdermal Delivery Systems) Distributors List Table 173. TDS(Transdermal Delivery Systems) Customers List Table 174. TDS(Transdermal Delivery Systems) Market Trends Table 175. TDS(Transdermal Delivery Systems) Market Drivers Table 176. TDS(Transdermal Delivery Systems) Market Challenges Table 177. TDS(Transdermal Delivery Systems) Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. TDS(Transdermal Delivery Systems) Product Picture Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2021 & 2027 Figure 6. Hospital Examples Figure 7. Clinic Examples Figure 8. Other Examples Figure 9. Global TDS(Transdermal Delivery Systems) Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global TDS(Transdermal Delivery Systems) Sales Growth Rate (2016-2027) & (US$ Million) Figure 11. Global TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2016-2027) Figure 12. Global TDS(Transdermal Delivery Systems) Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 13. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2016 VS 2021 Figure 14. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2021 VS 2027 Figure 15. North America TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 16. North America TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2016-2027) Figure 17. Europe TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 18. Europe TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027) Figure 19. China TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 20. China TDS(Transdermal Delivery Systems) Sales (Million USD) and Growth Rate (2016-2027) Figure 21. Japan TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 22. Japan TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027) Figure 25. India TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2016-2027) Figure 26. India TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2016-2027) Figure 27. Global 5 Largest TDS(Transdermal Delivery Systems) Players Market Share by Revenue in TDS(Transdermal Delivery Systems): 2016 & 2020 Figure 28. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2016-2021) Figure 30. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Type in 2016 & 2020 Figure 31. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2016-2021) Figure 32. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Application in 2016 & 2020 Figure 33. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 34. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 35. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 36. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 37. China TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 38. China TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 39. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 40. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 41. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 42. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 43. India TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 Figure 44. India TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of TDS(Transdermal Delivery Systems) Figure 47. Manufacturing Process Analysis of TDS(Transdermal Delivery Systems) Figure 48. TDS(Transdermal Delivery Systems) Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us